Inactivation of SARS-CoV-2 Through Treatment with the Mouth Rinsing Solutions ViruProX^® and BacterX^® Pro

by Julia Koch-Heier, Helen Hoffmann, Michael Schindler, Adrian Lussi, Oliver Planz
Published 2021-03-01

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

by Daniel E Demminger, Lisa Walz, Kristina Dietert, Helen Hoffmann, Oliver Planz, Achim D Gruber, Veronika vonMessling, Thorsten Wolff
Published 2020-05-01

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

by Hans-Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, Reinhild Klein, Beate Preuß, Juliane Sarah Walz, Annika Nelde, Sebastian P. Haen, Michael Reth, Jianying Yang, Ghazaleh Tabatabai, Hans Bösmüller, Helen Hoffmann, Michael Schindler, Oliver Planz, Karl-Heinz Wiesmüller, Markus W. Löffler
Published 2021-04-01